Moreover, cell-free mitochondrial DNA levels in plasma may serve as biomarker of anti-inflammatory treatment efficacy in ARDS [42], correlating with pulmonary inflammation and IL-6 production [43]. The gene discussed is IL6; the disease is acute respiratory distress syndrome.